Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the impact of RFK Jr.'s policies on US Covid-19 vaccination rates by end of 2025?
Increase by more than 5% • 25%
Decrease by more than 5% • 25%
No significant change • 25%
Fluctuate without clear trend • 25%
CDC vaccination rate reports
RFK Jr. Petitioned FDA in May 2021 to Revoke Covid-19 Vaccine Authorization Despite Saving 140,000 Lives
Jan 17, 2025, 10:28 PM
Robert F. Kennedy Jr., nominated by President-elect Donald Trump to lead the Department of Health and Human Services, petitioned the FDA in May 2021 to revoke the authorization of all Covid-19 vaccines. This action was taken during a critical phase of the pandemic when the vaccines were in high demand and considered life-saving, with estimates suggesting they had already saved about 140,000 lives in the United States. Kennedy's petition, filed on behalf of the nonprofit Children’s Health Defense, argued that the risks of the vaccines outweighed their benefits and suggested that alternative treatments like ivermectin and hydroxychloroquine were viable options, despite these treatments having been deemed ineffective against the virus. The FDA denied the petition, stating there was no basis to pull the vaccines from the market. Kennedy's stance on vaccines has drawn criticism, with some public health experts expressing concern over his potential impact on public health policy if confirmed as HHS Secretary.
View original story
No change • 25%
Increased distribution • 25%
Other • 25%
Decreased distribution • 25%
No significant change • 25%
Data unavailable • 25%
Decrease in vaccination rates • 25%
Increase in vaccination rates • 25%
Decreased vaccine skepticism • 25%
Insufficient data • 25%
No significant change • 25%
Increased vaccine skepticism • 25%
Data not available • 25%
Increase • 25%
Decrease • 25%
No significant change • 25%
Other • 25%
More favorable • 25%
Less favorable • 25%
Unchanged • 25%
Mixed results • 25%
Increase in trust • 25%
Decrease in trust • 25%
No change • 25%
Neutral • 25%
Mixed • 25%
Pro-vaccine • 25%
Anti-vaccine • 25%
Less favorable • 25%
More favorable • 25%
Divided opinion • 25%
No change • 25%
Unclear • 25%
Positive impact • 25%
Negative impact • 25%
No impact • 25%
Appointed but inactive • 25%
Appointed and active • 25%
Not appointed • 25%
Other outcome • 25%
Strong opposition • 25%
Neutral • 25%
Support • 25%
Moderate opposition • 25%
Looser Regulations • 25%
Stricter Regulations • 25%
Other Changes • 25%
No Significant Change • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Supports Both • 25%
Supports Neither • 25%
Supports Ivermectin • 25%
Supports Hydroxychloroquine • 25%